Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Harvard Business School
McKinsey
Boehringer Ingelheim
Medtronic

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

Pharmacia Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Pharmacia
International Patents:264
US Patents:7
Tradenames:106
Ingredients:83
NDAs:132

Drugs and US Patents for Pharmacia

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn NEO-MEDROL ACETATE methylprednisolone acetate; neomycin sulfate CREAM;TOPICAL 060611-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Pharmacia And Upjohn U-GENCIN gentamicin sulfate INJECTABLE;INJECTION 062248-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-005 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Pharmacia And Upjohn NEO-MEDROL methylprednisolone; neomycin sulfate OINTMENT;OPHTHALMIC 060645-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Pharmacia

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 3,507,954   Start Trial
Pharmacia And Upjohn NICOTROL nicotine INHALANT;ORAL 020714-001 May 2, 1997 5,501,236   Start Trial
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-003 May 1, 1984 3,454,635   Start Trial
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 3,507,961   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for PHARMACIA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe 2007-07-30
➤ Subscribe Oral Suspension 100 mg/5 mL ➤ Subscribe 2009-08-03
➤ Subscribe Injection 2 mg/mL, 100 mL bag ➤ Subscribe 2009-12-29
➤ Subscribe Tablets 600 mg ➤ Subscribe 2005-12-21
➤ Subscribe Injection 2 mg/mL, 300 mL bag ➤ Subscribe 2009-09-01
➤ Subscribe Tablets 1 g ➤ Subscribe 2005-08-23

Supplementary Protection Certificates for Pharmacia Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0809498 10C0038 France   Start Trial PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0136011 2000C/027 Belgium   Start Trial PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0334429 97C0002 Belgium   Start Trial PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305
0164865 C970030 Netherlands   Start Trial PRODUCT NAME: IBUTILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZOUT, IN HET BIJZONDER HET FUMARAAT; NAT. REGISTRATION NO/DATE: RVG 21286 19970612; FIRST REGISTRATION: GB PL 0032/0212 19960930
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Harvard Business School
Merck
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.